Great-West Lifeco Inc
GRWLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | -0.24 | 0.45 | 1.16 |
| FCF Yield | 25.52% | 31.25% | 28.94% | 43.56% |
| EV / EBITDA | 3.25 | 4.83 | 5.89 | 6.09 |
| Quality | ||||
| ROIC | -0.22% | -0.45% | 1.95% | 2.11% |
| Gross Margin | 38.56% | 30.28% | -410.73% | 20.06% |
| Cash Conversion Ratio | 0.99 | 1.81 | 1.87 | 2.68 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -17.09% | – | 12.93% |
| Free Cash Flow Growth | -8.69% | -26.17% | -32.06% | 7.94% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | 0.65 | 0.98 | 1.05 |
| Interest Coverage | -5.31 | -8.13 | 10.72 | 11.58 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 9.09 | 11.71 | 73.19 | 2.21 |